Drug eluting stent in urology

Area of Science:

• Interventional Cardiology
• Urological Surgery
• Biomedical Engineering

Background:

• Drug-eluting stents (DESs) are standard in cardiology, minimizing restenosis via antiproliferative drugs.
• Urological stents are crucial but associated with complications like infection, discomfort, and hyperplastic reactions.
• The application of DES technology to urology aims to mitigate these complications.

Purpose of the Study:

• To explore the potential of drug-eluting stents (DESs) in urological practice.
• To review the current experimental and limited clinical evaluations of urological DESs.
• To identify key factors for developing effective urological DESs.

Main Methods:

• Review of existing literature on DESs in interventional cardiology and urology.
• Analysis of experimental studies evaluating ureteral and urethral DESs (polymeric and metal).
• Assessment of limited clinical data available for polymeric urological DESs.

Main Results:

• DESs effectively reduce smooth muscle proliferation and restenosis in coronary arteries.
• Experimental studies have explored various urological DES designs.
• Clinical evidence for urological DESs is currently limited, primarily focusing on polymeric stents, and requires further validation.

Conclusions:

• Adapting DES technology to urology holds potential for reducing stent-related complications.
• Further research and development are essential for selecting appropriate materials and conducting robust clinical investigations.
• Successful implementation of urological DESs requires comprehensive experimental and clinical validation.